Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/28/2002WO2002094177A2 Novel nucleic acids and their therapeutic use in ophthalmology
11/28/2002WO2002094176A2 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
11/28/2002WO2002094123A2 Method of preparing a dought with an enzime
11/28/2002WO2002094016A1 Knockin nonhuman animal producing human tissue factor
11/28/2002WO2002094008A2 Transgenic plants protected against parasitic plants
11/28/2002WO2002083712A8 Transporters and ion channels
11/28/2002WO2002081631A3 Uncoupled productive and catabolic host cell pathways
11/28/2002WO2002080648A3 Mucosal boosting following parenteral priming
11/28/2002WO2002078835A3 Substrates, preparation and use
11/28/2002WO2002077185A3 Methods for modifying flowering phenotypes
11/28/2002WO2002072781A3 Electromanipulation device and method
11/28/2002WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002WO2002068652A9 Nov-x proteins and nucleic acids encoding same
11/28/2002WO2002068606A3 Methods for the identification of herbicides and the modulation of plant growth
11/28/2002WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002WO2002066599A3 Efficient method for the development of transgenic plants by gene manipulation
11/28/2002WO2002063019A3 Methods for generating resistance against cgmmv in plants
11/28/2002WO2002062979A3 Enzyme
11/28/2002WO2002061038A9 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
11/28/2002WO2002059333A9 Gene promoters isolated from potato and use thereof
11/28/2002WO2002056837A9 Inhibition of protein-phosphatases for the treatment of heart failure
11/28/2002WO2002050304A3 Oncolytic virus
11/28/2002WO2002040538A3 Regulation of human nmda receptor
11/28/2002WO2002038782A3 Viral expression system
11/28/2002WO2002038727A3 Dna sequences encoding proteins conferring phytophthora infestans resistance on plants
11/28/2002WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002WO2002034920A3 Regulation of human ceruloplasmin-like protein
11/28/2002WO2002034906A3 Method for exposing peptides and polypeptides on the cell surface of bacteria
11/28/2002WO2002034040A3 Method for generating transgenic fish embryos using an episomal vector system
11/28/2002WO2002029049A3 Regulation of human sodium-dependent monoamine transporter
11/28/2002WO2002026991A3 Gene 4
11/28/2002WO2002024924A3 Protein phosphatases
11/28/2002WO2002022791A3 Regulation of human pyridoxine 5'-phosphate oxidase
11/28/2002WO2002022665A9 Novel g protein-coupled receptor proteins and dnas tehreof
11/28/2002WO2002022177A3 High efficiency cardiac gene transfer
11/28/2002WO2002016579A3 Nucleic acids, vectors, host cells, polypeptides and uses thereof
11/28/2002WO2002014486A3 Inhibition of generative propagation in genetically modified grasses
11/28/2002WO2002008442A9 Means and methods for raising antibody concentration in compartments of the body of a non human animal
11/28/2002WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002WO2001098528A3 Method for detecting cytosine methylations
11/28/2002WO2001098509A3 Grain processing method and transgenic plants useful therein
11/28/2002WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002WO2001090345A3 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/28/2002WO2001085764A3 Regulation of human p2y-like g protein-coupled receptor
11/28/2002WO2001081623A3 Neuronally expressed protein having apoptotic activity, and use thereof
11/28/2002WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002WO2001079275A3 STAPHYLOCOCCAL GENE, vgaC, CONFERRING RESISTANCE TO STREPTOGRAMIN A AND RELATED COMPOUNDS
11/28/2002WO2001073108A3 A bacterial two-hybrid system for protein interaction screening
11/28/2002WO2001071040A3 Method for determination of gene function
11/28/2002WO2001070954A9 Regulation of human nerve growth factor-elated g protein-coupled receptor
11/28/2002WO2001068911A3 Diagnosis of diseases associated with the cell cycle
11/28/2002WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002WO2001042473A9 Device and method for accelerated hydration of dry chemical sensors
11/28/2002WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002WO2001016378A9 Chromosome-wide analysis of protein-dna interactions
11/28/2002WO2000072004A3 Method of determining the three-dimensional shape of a macromolecule
11/28/2002US20020178468 Nucleotide sequences coding polypeptide for use in the transport of carbohydrates throughout plant cells
11/28/2002US20020178467 Expression vector for use in the transformation of plant organelles
11/28/2002US20020178466 Reduction of lignification in vascular plants; obtain plant cells, transfrom plant with expression vector coding polypeptide associate with gene expressin inhibition, monitor plant for adjustment preferential gene transcription
11/28/2002US20020178465 Selective control of lignin biosynthesis in transgenic plants
11/28/2002US20020178464 Proton transporters and uses in plants
11/28/2002US20020178463 Method for transforming monocotyledons
11/28/2002US20020178462 Prenatal screening
11/28/2002US20020178461 Transgenic fish with tissue-specific expression
11/28/2002US20020178460 Animal model for use as tools in genetic engineering
11/28/2002US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002US20020178457 Transgenic animals; genetic engineering
11/28/2002US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002US20020177885 Method and device for selectively targeting cells within a three-dimensional specimen
11/28/2002US20020177696 Compositions and methods relating to breast specific genes and proteins
11/28/2002US20020177691 Geenrating preferential protein; obtain nucleotide sequences coding for preferential protein domains, fuse, transfer vector in to cells, express vector, recover protein
11/28/2002US20020177690 Novel antimicrobial polypeptides and methods of use
11/28/2002US20020177689 Compounds for the treatment of sexual dysfunction
11/28/2002US20020177572 Viral infection of cells
11/28/2002US20020177571 Retroviral vector particle comprising a modified viral surface protein for targeting the vector (especially to the Von Willebrand factor) and a cytokine gene.
11/28/2002US20020177568 Enzymatic nucleic acid treatment of diseases or conditions related to levels of NF-kappa B
11/28/2002US20020177567 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal.
11/28/2002US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002US20020177564 DNA construct comprising said exogenous gene under the control of an ecdysone response element; and a modified ecdysone receptor which, in the presence of a ligand therefor, binds to said ecdysone response element
11/28/2002US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002US20020177550 Administering to the subject a therapeutically effective amount of a form of soluble Receptor for Advanced Glycation Endproducts (RAGE).
11/28/2002US20020177549 Which regulate cellular guidance and physiology, and related nucleic acids.
11/28/2002US20020177544 Adenoviral transfer vector for the gene transport of a dna sequence
11/28/2002US20020177242 Retentate chromatography and protein chip arrays with applications in biology and medicine
11/28/2002US20020177230 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome
11/28/2002US20020177229 Swap/counter selection: a rapid cloning method
11/28/2002US20020177222 Replication competent AAV helper functions
11/28/2002US20020177217 Monitoring protein associations; obtain cells, screen library, obtain clone, transform cells with clones, express proteins, recover and detect protein associations
11/28/2002US20020177216 Culturing preferential mammalian virus; obtain mammalian cells, infect cell with virus, culture cells and recover viral particles
11/28/2002US20020177215 Methods for producing purified adenoviral vectors
11/28/2002US20020177213 Tissue plasminogen activator-like protease
11/28/2002US20020177210 Polypeptide for use as tools in food processing and genetic engineering
11/28/2002US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002US20020177208 Polypeptide for use in the diagnosis, treatment and prevention of cancer and inflammation
11/28/2002US20020177207 Tsg101-interacting proteins and use thereof